Idexx Laboratories (IDXX) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Idexx Laboratories · Health Care · ref. ETF XLV · 50 calls · price $545.08
What the company does: IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
📈 Idexx Laboratories (IDXX) stock price
$545.08-15.8% over range
Aug 28, 25low $526.44 · high $766.68Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
50% recommend buying · 4 analysts
📊 JPI status : Idexx Laboratories has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 IDXX price target & analyst consensus — price $545
The price target · all analysts combined (4 targets)
Highest target · 1 firm of 4$710+30.3%
Median target · of 4 targets$672.5+23.4%
Lowest target · 2 firms of 4$670+22.9%
Current price$545.08
Where these 4 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
4100%
$670 ↔ $710
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Citigroup — 66% of its targets hit on this sector (508 calls tested). It aims for $670 (+23 %), call made on August 6, 2026, maturing on August 6, 2027 (22 d ago).
The 3 reliable analysts
$670+23 %
The 1 other firm
$675+24 %
How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $670 median. “The 1 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 4 ratings (last 6 months)
Strong Buy00%
Buy250%
Hold250%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 IDXX price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on IDXX most reliable
Their real reliability on IDXX, firm by firm: who was right, who was wrong.
→ See their reliability on IDXXAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Idexx Laboratories? The JPI assistant answers using our backtest data.
📈 Idexx Laboratories fundamentals: valuation, margins & growth › open the full page
P/E 38.9Net margin 25.0 %Revenue growth +9.7 %Fairly valued
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 20 %
2023
Rev +9%Profit +24%
2024
Rev +6%Profit +5%
2025
Rev +10%Profit +19%
🔎 Detailed analyses
✅ Historical analyst reliability on IDXX
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| B of A Securities ↗ | 100% | +40.0% | 5 |
| Leerink Partners ↗ | 100% | +28.7% | 3 |
| Piper Sandler ↗ | 100% | +26.2% | 4 |
| Stifel ↗ | 90% | +39.1% | 10 |
| Credit Suisse | 88% | +39.7% | 8 |
| Atlantic Equities | 67% | +9.2% | 6 |
| Morgan Stanley ↗ | 57% | +10.7% | 14 |
| Canaccord Genuity ↗ | 50% | +7.9% | 4 |
| Goldman Sachs ↗ | 50% | +6.2% | 4 |
| JP Morgan ↗ | 50% | +5.0% | 8 |
📊 What $1,000 invested in Idexx Laboratories would be worth › open the full page
In short — $1,000 invested in Idexx Laboratories 10 years ago would be worth $7,219 today, i.e. +22%/yr on average. Best year: 2020 (+91%), worst: 2022 (-38%). Price performance, excluding dividends.
If I'd invested $1,000 in Idexx Laboratories
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,273 | +27% |
| 3 years ago | $1,290 | +29% |
| 5 years ago | $1,053 | +5% |
Return by year (Idexx Laboratories)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -22% | $778 (-22%) |
| 2025 | +64% | $1,273 (+27%) |
| 2024 | -26% | $948 (-5%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Idexx Laboratories
Loading news…
📋 All analyst calls on IDXX
Filtered on — · ✕ show all
▲ Overweight · 🎯$710
Price at call : $570.58 — upside +24%
Today : $545.08 — upside +30%
🎯 on IDXX : 67% (3 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Aug 11, 27
matures : Aug 11, 27
■ Neutral neutral · not a buy · 🎯$670
Price at call : $590 — gap to target +14%
Today : $545.08 — gap to target +23%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
■ Neutral neutral · not a buy · 🎯$670
Price at call : $590 — gap to target +14%
Today : $545.08 — gap to target +23%
🎯 on IDXX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
■ Neutral neutral · not a buy · 🎯$620
Price at call : $569.54 — gap to target +9%
Today : $545.08 — gap to target +14%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
■ Neutral neutral · not a buy · 🎯$640
Price at call : $553.66 — gap to target +16%
Today : $545.08 — gap to target +17%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Apr 28, 27
matures : Apr 28, 27
■ Neutral neutral · not a buy · 🎯$650
Price at call : $569.95 — gap to target +14%
Today : $545.08 — gap to target +19%
🎯 on IDXX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
▲ Buy · 🎯$675
Price at call : $564.66 — upside +20%
Today : $545.08 — upside +24%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Mar 31, 27
matures : Mar 31, 27
Piper Sandler ↗
Feb 9, 26
■ Neutral neutral · not a buy · 🎯$750
Price at call : $646.53 — gap to target +16%
Today : $545.08 — gap to target +38%
🎯 on IDXX : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
See the other 42 calls, newest to oldest
▲ Overweight · 🎯$800
Price at call : $644.61 — upside +24%
Today : $545.08 — upside +47%
🎯 on IDXX : 67% (3 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
■ Neutral neutral · not a buy · 🎯$730
Price at call : $632.56 — gap to target +15%
Today : $545.08 — gap to target +34%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
▲ Buy · 🎯$800
Price at call : $632.56 — upside +26%
Today : $545.08 — upside +47%
🎯 on IDXX : 100% (1 call matured) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
▲ Overweight · 🎯$850
Price at call : $701.83 — upside +21%
Today : $545.08 — upside +56%
🎯 on IDXX : 67% (3 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
Morgan Stanley ↗
Nov 4, 25
▲ Overweight · 🎯$805
Price at call : $720.21 — upside +12%
Today : $545.08 — upside +48%
🎯 on IDXX : 50% (8 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
■ Neutral neutral · not a buy · 🎯$750
Price at call : $720.21 — gap to target +4%
Today : $545.08 — gap to target +38%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
▲ Overweight · 🎯$775
Price at call : $720.21 — upside +8%
Today : $545.08 — upside +42%
🎯 on IDXX : 33% (3 calls matureds) · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
▲ Buy · 🎯$830
Price at call : $722.12 — upside +15%
Today : $545.08 — upside +52%
🎯 on IDXX : 100% (1 call matured) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
▲ Buy · 🎯$700
Price at call : $629.51 — upside +11%
Today : $545.08 — upside +28%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
■ Neutral neutral · not a buy · 🎯$720
Price at call : $620.11 — gap to target +16%
Today : $545.08 — gap to target +32%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Oct 1, 26
matures : Oct 1, 26
Morgan Stanley ↗
Aug 15, 25
▲ Overweight · 🎯$765
Price at call : $650.84 — upside +18%
Today : $545.08 — upside +40%
Expected +18% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 50% (8 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
-16.1%
stock -16% · XLV +23%
matured Aug 15, 26
Piper Sandler ↗
Aug 11, 25
■ Neutral neutral · not a buy · 🎯$700
Price at call : $652.11 — gap to target +7%
Today : $545.08 — gap to target +28%
🎯 on IDXX : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Aug 11, 26
matures : Aug 11, 26
▲ Overweight · 🎯$675
Price at call : $641.94 — upside +5%
Today : $545.08 — upside +24%
Expected +5% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 33% (3 calls matureds) · 📊 on Health : 53.8% · +5.3% (355 calls)
-8.9%
stock -9% · XLV +24%
matured Aug 4, 26
Morgan Stanley ↗
Aug 4, 25
▲ Overweight · 🎯$722
Price at call : $641.94 — upside +12%
Today : $545.08 — upside +32%
Expected +12% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 50% (8 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
-8.9%
stock -9% · XLV +24%
matured Aug 4, 26
Morgan Stanley ↗
Jul 29, 25
▲ Overweight · 🎯$628
Price at call : $572.09 — upside +10%
Today : $545.08 — upside +15%
Expected +10% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 50% (8 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
-2.3%
stock -2% · XLV +22%
matured Jul 29, 26
Leerink Partners ↗
Jul 17, 25
▲ Outperform · 🎯$600
Price at call : $514.61 — upside +17%
Today : $545.08 — upside +10%
Expected +17% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 100% (3 calls matureds) · 📊 on Health : 55.3% · -4.8% (38 calls)
+9.6%
stock +10% · XLV +21%
matured Jul 17, 26
■ Hold neutral · not a buy · 🎯$540
Price at call : $547.01 — gap to target -1%
Today : $545.08 — gap to target -1%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Jul 2, 26
matures : Jul 2, 26
Leerink Partners ↗
Jun 11, 25
▲ Outperform · 🎯$580
Price at call : $526.92 — upside +10%
Today : $545.08 — upside +6%
Expected +10% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 100% (3 calls matureds) · 📊 on Health : 55.3% · -4.8% (38 calls)
+6.5%
stock +6% · XLV +12%
matured Jun 11, 26
■ Hold neutral · not a buy · 🎯$510
Price at call : $517.16 — gap to target -1%
Today : $545.08 — gap to target -6%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : May 19, 26
matures : May 19, 26
Morgan Stanley ↗
May 5, 25
▲ Overweight · 🎯$558
Price at call : $473.71 — upside +18%
Today : $545.08 — upside +2%
Expected +18% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 50% (8 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+22.3%
stock +22% · XLV +8%
matured May 5, 26
■ Hold neutral · not a buy · 🎯$460
Price at call : $471.38 — gap to target -2%
Today : $545.08 — gap to target -16%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : May 1, 26
matures : May 1, 26
B of A Securities ↗
Apr 21, 25
■ Neutral neutral · not a buy · 🎯$475
Price at call : $421.59 — gap to target +13%
Today : $545.08 — gap to target -13%
🎯 on IDXX : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Apr 21, 26
matures : Apr 21, 26
Morgan Stanley ↗
Apr 15, 25
▲ Overweight · 🎯$548
Price at call : $402.38 — upside +36%
Today : $545.08 — upside +1%
Expected +36% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 50% (8 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+41.6%
stock +42% · XLV +8%
matured Apr 15, 26
■ Hold neutral · not a buy · 🎯$420
Price at call : $404.02 — gap to target +4%
Today : $545.08 — gap to target -23%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Apr 14, 26
matures : Apr 14, 26
■ Hold neutral · not a buy · 🎯$450
Price at call : $437.11 — gap to target +3%
Today : $545.08 — gap to target -17%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Feb 28, 26
matures : Feb 28, 26
Piper Sandler ↗
Feb 10, 25
■ Neutral neutral · not a buy · 🎯$510
Price at call : $463.74 — gap to target +10%
Today : $545.08 — gap to target -6%
🎯 on IDXX : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Feb 10, 26
matures : Feb 10, 26
Morgan Stanley ↗
Feb 4, 25
▲ Overweight · 🎯$559
Price at call : $468.55 — upside +19%
Today : $545.08 — upside +3%
Expected +19% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 50% (8 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+37.4%
stock +37% · XLV +4%
matured Feb 4, 26
▲ Overweight · 🎯$520
Price at call : $465.03 — upside +12%
Today : $545.08 — upside -5%
Expected +12% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 67% (3 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
+38.3%
stock +38% · XLV +6%
matured Feb 4, 26
B of A Securities ↗
Feb 4, 25
■ Neutral neutral · not a buy · 🎯$535
Price at call : $465.03 — gap to target +15%
Today : $545.08 — gap to target -2%
🎯 on IDXX : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Feb 4, 26
matures : Feb 4, 26
■ Hold neutral · not a buy · 🎯$460
Price at call : $469.04 — gap to target -2%
Today : $545.08 — gap to target -16%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Feb 3, 26
matures : Feb 3, 26
Morgan Stanley ↗
Jan 29, 25
▲ Overweight · 🎯$550
Price at call : $423.99 — upside +30%
Today : $545.08 — upside +1%
Expected +30% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 50% (8 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+58.1%
stock +58% · XLV +5%
matured Jan 29, 26
Leerink Partners ↗
Dec 2, 24
▲ Outperform · 🎯$500
Price at call : $430.77 — upside +16%
Today : $545.08 — upside -8%
Expected +16% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 100% (3 calls matureds) · 📊 on Health : 55.3% · -4.8% (38 calls)
+70.1%
stock +70% · XLV +5%
matured Dec 2, 25
Piper Sandler ↗
Nov 4, 24
■ Neutral neutral · not a buy · 🎯$435
Price at call : $415.98 — gap to target +5%
Today : $545.08 — gap to target -20%
🎯 on IDXX : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Nov 4, 25
matures : Nov 4, 25
▲ Overweight · 🎯$481
Price at call : $414.52 — upside +16%
Today : $545.08 — upside -12%
Expected +16% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 67% (3 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
+74.2%
stock +74% · XLV -1%
matured Nov 4, 25
▲ Overweight · 🎯$575
Price at call : $478 — upside +20%
Today : $545.08 — upside +5%
Expected +20% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 33% (3 calls matureds) · 📊 on Health : 53.8% · +5.3% (355 calls)
+32.5%
stock +32% · XLV -8%
matured Oct 11, 25
■ Hold neutral · not a buy · 🎯$500
Price at call : $476.27 — gap to target +5%
Today : $545.08 — gap to target -8%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Oct 10, 25
matures : Oct 10, 25
Piper Sandler ↗
Aug 14, 24
■ Neutral neutral · not a buy · 🎯$520
Price at call : $485.52 — gap to target +7%
Today : $545.08 — gap to target -5%
🎯 on IDXX : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Aug 14, 25
matures : Aug 14, 25
▲ Buy · 🎯$580
Price at call : $469.71 — upside +23%
Today : $545.08 — upside +6%
Expected +23% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on IDXX : 100% (1 call matured) · 📊 on Health : 54.8% · +8.3% (115 calls)
+20.6%
stock +21% · XLV -10%
matured Jul 25, 25
■ Hold neutral · not a buy · 🎯$510
Price at call : $491.49 — gap to target +4%
Today : $545.08 — gap to target -6%
🎯 on IDXX : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Jun 24, 25
matures : Jun 24, 25
Morgan Stanley ↗
May 14, 24
▲ Overweight · 🎯$596
Price at call : $548.53 — upside +9%
Today : $545.08 — upside +9%
Expected +9% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 50% (8 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
-6.7%
stock -7% · XLV -11%
matured May 14, 25
▲ Overweight · 🎯$570
Price at call : $480.6 — upside +19%
Today : $545.08 — upside +5%
Expected +19% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on IDXX : 67% (3 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
-1.1%
stock -1% · XLV -2%
matured May 2, 25
Frequently asked questions
Should I buy Idexx Laboratories stock?
This isn't buy advice. For Idexx Laboratories, the analyst consensus is "Buy", with an average price target of $673 (+23% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (5 calls tracked on Idexx Laboratories). We show the numbers — you decide.
Is it too late to buy Idexx Laboratories? How high can it go?
The most bullish analyst target on Idexx Laboratories is $710 (+30% above today's price); the average is $673. That's the upside they see. Check how reliable those analysts have actually been on Idexx Laboratories on our site before trusting it.
Is Idexx Laboratories still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on Idexx Laboratories, the best hitting 100% over 5 calls. Current consensus: "Buy". Make your call on data, not noise.
What has Idexx Laboratories's past performance been?
Historical returns and a "how much if I had invested" calculator: IDXX performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX